VIDA Maestro

Advanced Imaging CRO: Digitized trial orchestration ensures quality, efficient site operations, and reliable imaging biomarker endpoints.

Connect with an Expert
VIDA Maestro visualization

Accelerating Clinical Trials with High-Quality Quantitative Imaging

VIDA Maestro is a quantitative trial imaging solution that modernizes clinical studies by digitizing site workflows, standardizing imaging across 100+ protocols, and ensuring high-quality, consistent data. It accelerates onboarding, supports global sites with multilingual capabilities, and securely manages and analyzes data through advanced biomarkers and AI integrations—delivering faster setup, higher scan yield, and more reliable insights for critical decisions.

How VIDA Maestro Works

Advanced Imaging CRO

Going far beyond a traditional imaging CRO, VIDA Maestro solves the unique challenges of bringing advanced biomarkers to your clinical trials with quality and performance expected for both small and large global Phase II/III/IV trials.

Key AdvantagesExperience
100+
Advanced Imaging Trials
1B+
Advanced Imaging Trials

Orchestrate 
Your Evidence. Accelerate Your Trial.

VIDA Maestro is built for pharmaceutical sponsors running multi-site trials with imaging endpoints, helping teams improve oversight, reduce operational drag, and keep complex imaging programs moving with confidence.

Empower your Team to Orchestrate Every Detail:

  • Seamlessly manage complex imaging endpoints across respiratory, oncology, and cardiovascular studies.
  • Centralize imaging oversight across multiple sites and CROs through a single, orchestrated platform.
  • Proactively reduce screen failures, protocol deviations, and avoidable trial delays.
  • Replace manual QC and site queries with automated, intelligent workflows.
  • Harness validated, regulatory-grade imaging biomarkers.
  • Command complex imaging protocols across global trials.

Better Imaging Oversight 
for Better Trial Outcomes

Data Quality & Consistency

  • Interclass correlation coefficient (ICC) of 90%+ for most biomarkers.
  • Scan yield 90%+.
  • AI-driven QC, with humans in the loop.

Operational Efficiency

  • Site activation accelerated by 50%.
  • Rapid scan turn-around.
  • Proactive trial monitoring.

Intelligent Data & Analysis

  • Build sponsor private biobank, powers insights.
  • 100’s of Publications on analysis methodologies.
  • Track quality metrics on images 
& biomarkers.